**Core Concept:** Epithelial-mesenchymal transition (EMT) is a process that occurs during development, tissue repair, and pathological conditions like cancer. It involves the conversion of epithelial cells into more migratory and invasive mesenchymal cells. Metastatic genes are those that contribute to the progression of epithelial tumors by promoting EMT.

**Why the Correct Answer is Right:** The correct answer is **D**: **Vimentin (VIM)** is an intermediate filament protein essential for maintaining cell structure and function. Vimentin is upregulated during EMT, leading to increased cell migration, invasion, and resistance to apoptosis. In epithelial tumors, vimentin contributes to the progression of the disease by promoting EMT.

**Why Each Wrong Option is Incorrect:**

A. **Snail (SNAI1)** is a transcription factor that represses epithelial genes and activates mesenchymal genes, including Vimentin (D). While Snail is involved in EMT, it does not directly code for a protein like Vimentin does.

B. **Twist (TWIST1)** is another transcription factor that plays a crucial role in EMT, but it doesn't code for a protein that directly contributes to the progression of epithelial tumors via EMT.

C. **Zeb1 (SIP1)** is a transcription factor involved in EMT, but it does not code for a protein that directly contributes to the progression of epithelial tumors via EMT.

**Clinical Pearl:** Understanding EMT and its genes can help in developing targeted therapies for epithelial cancers. Targeting these genes may prevent or revert the EMT process, thus halting tumor progression and improving patient outcomes.